AzTrials
AzTrials

HealthyNCT05957393

Improving Physician Vaccine Recommendation Using Social Norms, Trust, and Presumptive Language

A study testing Quantity of vaccination recommendations and Quality of vaccination recommendations in people with Healthy, run by Duke University at 3 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research examines vaccination recommendation perceptions and behaviors of physicians and advanced practice providers. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Quantity of vaccination recommendations and Quality of vaccination recommendations
Type of treatment
Vaccines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
447 participants
Where
3 sitesin 2 countries
Study dates
21 Sep 2023to 24 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants must be physicians, advanced practice providers, medical students, nurses/nurse practitioners, or medical fellows.
  • Must be in a position to be authorized to recommend vaccines to patients in their official professional capacities/responsibilities.

Who cannot join

  • Students or employees under the supervision of the PI who meet inclusion criteria for the study

Trial locations and contacts

3 sites in 2 countries.

3 sites in 2 countries

United States2 sites
  • (Any and all facilities) - The study team ask(s)/(ed) professional contacts, friends, and family members who are employed at various US Institutions to forward the recruitment announcement message via their respective networks

    Durham, North Carolina, 27710

  • Duke University Health System (all locations)

    Durham, North Carolina, 27710

Other trials in United States

Brazil1 site
  • (Any and all facilities) - Participants are recruited via market research company "Survey Healthcare Global"

    Brasília

Other trials in Brazil

About this study

This research examines vaccination recommendation perceptions and behaviors of physicians and advanced practice providers.

Conditions
Healthy
Being tested
Quantity of vaccination recommendations, Quality of vaccination recommendations, Control
Keywords
Physicians, Vaccination Recommendation, Social Norms, Trust, Presumptive Recommendation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quantity of vaccination recommendationsOther

    The survey contains a messaging intervention using a 2x2 randomized factorial design, where the investigators attempt to increase the quantity and/or quality of physician and APP vaccination recommendations (Quantity (present vs. absent) x Quality (present vs. absent)).

  • Quality of vaccination recommendationsOther

    The survey contains a messaging intervention using a 2x2 randomized factorial design, where the investigators attempt to increase the quantity and/or quality of physician and APP vaccination recommendations (Quantity (present vs. absent) x Quality (present vs. absent)).

  • ControlOther

    The survey contains a messaging intervention using a 2x2 randomized factorial design, where the investigators attempt to increase the quantity and/or quality of physician and APP vaccination recommendations (Quantity (present vs. absent) x Quality (present vs. absent)).

Study groups in NCT05957393
Study groupRoleWhat they receive
Quantity (present) x Quality (present)ExperimentalParticipants will receive a social norm-based message (for quantity) and will learn the AIMS method, a trust-building method using presumptive language (for quality).
Receives: Other: Quantity of vaccination recommendations; Other: Quality of vaccination recommendations
Quantity (present) x Quality (absent)ExperimentalParticipants will receive a social norm-based message (for quantity).
Receives: Other: Quantity of vaccination recommendations
Quantity (absent) x Quality (present)ExperimentalParticipants will learn the AIMS method, a trust-building method using presumptive language (for quality).
Receives: Other: Quality of vaccination recommendations
Quantity (absent) x Quality (absent)ExperimentalControl: Participants in this condition will receive general information about vaccines, including vaccine principles, uptake barriers, and guidelines. This information will come directly from the CDC's Advisory Committee on Immunization Practices (ACIP) website.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in proportion of patients that receive a vaccine recommendation

    Proportion of patients that receive a vaccine recommendation = multiplication of the answer to the following two items: (1) "I (will) check(ed) whether a patient has/had gotten all indicated vaccines", (2) "If I saw/see a patient had not gotten an indicated vaccine, I (will) discuss(ed) getting it." Both items are answered on a scale from 0% (never) to 100% (always).

    Measured: Day 1, Day 30, Day 60, Day 90

  2. Change in self-reported responsibility perception

    Self-reported responsibility perception = answer to the following item: (1) "Recommending indicated vaccines is within the scope of my professional responsibilities". This item is answered on a scale from 0% (completely disagree) to 100% (completely agree).

    Measured: Day 1, Day 30, Day 60, Day 90

  3. Change in self-reported assessment of patient recommendation acceptance

    Self-reported assessment of patient recommendation acceptance = answer to the following item: (1) "If I recommend(ed) an indicated vaccine, my patient (will) accept(ed) that recommendation.". This item is answered on a scale from 0% (never) to 100% (always).

    Measured: Day 1, Day 30, Day 60, Day 90

  4. Change in self-reported patient trust

    Self-reported patient trust = answer to the following item: (1) "Thinking about the last/next 30 days I provided care, I can say that my patients (will) trust(ed) me as their healthcare provider". This item is answered on a scale from 0% (completely disagree) to 100% (completely agree).

    Measured: Day 1, Day 30, Day 60, Day 90

  5. Change in self-reported utilization of AIMS

    Composite score of the following items: (1) "I used/will use direct, declarative language, like: "You're due for your flu shot. We'll do that at the end of this visit"; (2) "If the patient showed/shows hesitancy about getting vaccinated, I (will) ask(ed) about their concerns, and then use(d) active listening to understand their thoughts"; (3) "If the patient showed/shows hesitancy about getting vaccinated, I (will) listen(ed) to the patient's reasoning and then summarize(d) the patient's reasoning back to them to show that I understood/understand"; (4) "If the patient still has concerns, I did/will not continue efforts to convince them."

    Each item is answered on a scale from 0% (never) to 100% (always).

    Measured: Day 1, Day 30, Day 60, Day 90

  6. Change in self-reported rate of patient vaccine uptake

    Answer to the following item: "Estimate what percentage of your patients is/will be fully vaccinated against […]" This item is answered on a scale from 0% to 100%.

    The question is being asked 8-10 times with the following name inserted for [...] in the above question:

    Flu COVID-19 Tetanus, Diphtheria, Pertussis HPV Hepatitis B Meningitis / Meningococcal Shingles Pneumococcal Other (which can be two other diseases that the respondent indicated)

    Measured: Day 1, Day 30, Day 60, Day 90

Secondary outcomes (2)
  1. Change in belief about patient autonomy

    Answer to the following item: "I stated / will state the patient's options - to vaccinate or not, and with which vaccine - so that they can make an informed decision." This item is answered on a scale from 0% to 100%.

    Measured: Day 1, Day 30, Day 60, Day 90

  2. Change in proportion of patients that accept a recommendation

    Proportion of patients that accept a recommendation = multiplication of the answer to the following three items: (1) "I (will) check(ed) whether a patient has/had gotten all indicated vaccines", (2) "If I saw/see a patient had not gotten an indicated vaccine, I (will) discuss(ed) getting it."; (3) "If I recommend(ed) an indicated vaccine, my patient (will) accept(ed) that recommendation." All items are answered on a scale from 0% (never) to 100% (always).

    Measured: Day 1, Day 30, Day 60, Day 90

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2023
  2. Study start21 Sep 2023
  3. Primary completion24 Apr 2024
  4. Study completion24 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Participant
Enrolment
447 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05957393
Sponsor's protocol ID
Pro00113696
Status last verified
Oct 2023
First submitted
14 Jul 2023
Last updated
1 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Personal information will be permanently removed from the data no later than two weeks after the distribution of the final study survey, after which study responses will no longer be able to be linked to an individual participant. What specific individual participant data sets are to be shared: Answers to all questions in all surveys will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Quantity of vaccination recommendations and Quality of vaccination recommendations in people with Healthy, run by Duke University at 3 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States, Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in proportion of patients that receive a vaccine recommendation (time frame: Day 1, Day 30, Day 60, Day 90). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in